Skip to main navigation Pipeline Roivant Discovery Roivant Health Investor Relations People Join Us Contact Corporate Profile Roivant's mission is to improve the delivery of healthcare to patients by treating every inefficiency as an opportunity. Roivant develops transformative medicines faster by building technologies and developing talent in creative ways, leveraging the Roivant platform to launch Vants – nimble and focused biopharmaceutical and health technology companies. Stock Information NASDAQ: ROIV $7.00 November 29, 2021 4:00 PM EST Change0 (0.00%) Volume0 Today's Open-- Previous Close$7.00 Today's High$7.08 Today's Low$6.86 52 Week High$10.87 52 Week Low$5.80 Data Provided by Refinitiv. Minimum 15 minutes delayed. Press Releases November 15, 2021 Roivant Sciences Reports Financial Results for the Quarter Ended September 30, 2021 and Provides Business Update READ MORE November 8, 2021 Roivant to Report Financial Results for the Quarter Ended September 30, 2021 on Monday, November 15, 2021 READ MORE October 1, 2021 Roivant Sciences Announces Close of Business Combination with Montes Archimedes Acquisition Corp. and Concurrent PIPE Financing READ MORE September 21, 2021 Roivant Sciences Reports First Fiscal Quarter 2021 Financial Results and Provides Business Update READ MORE June 9, 2021 Roivant Provides Corporate Updates READ MORE May 3, 2021 Roivant Sciences and Montes Archimedes Acquisition Corp. (MAAC) to Combine and Create Publicly Traded Leader in Biopharma and Health Technology READ MORE MORE PRESS RELEASES Print Page Email Alerts RSS Feeds IR Contacts © 2021 ROIVANT SCIENCES LTD. CAREERS PRIVACY POLICY